In a follow-up to her recent white paper on the future of the biotech sector, our resident...
Charles joined Platinum in 2014 as an investment specialist. Having previously worked in similar capacities at IFM Investors and Northward Capital / nabInvest, he brings with.. More
If we want to live up to the admirable ambition from both corporations and governments of achieving the target of net zero carbon emissions, we have a long way to go, and we need to get a move on.
Andrew co-founded Platinum in 1994 as the Deputy Chief Investment Officer, having worked alongside Kerr Neilson for several years at Bankers Trust and perfecting the craft of.. More
CEO and co-CIO Andrew Clifford talks with investment specialist Douglas Isles about many of the issues on our investors’ minds, covering China regulation, income inequality/redistribution, rising inflation and what it...
Bianca embarked on a career change in 2003 and joined Platinum as an investment analyst. Her rich knowledge base in molecular biology and first-hand insights into the.. More
COVID-19 has placed the healthcare sector front and centre in all our minds. The development of a vaccine in record time was truly remarkable, showing what can be achieved when great minds and innovative technology come together. Once the 'poor cousin', the biotech sector is coming...
In this recently recorded webinar, Co-Chief Investment Officer and co-portfolio manager for Platinum’s global strategies, Clay Smolinski and co-portfolio manager for our Asia ex-Japan strategies, Cameron Robertson provide...
Property developer China Evergrande Group is receiving considerable media attention due to its current financial woes. We think the Evergrande issue is unlikely to be systemic, due to its nature and the lack of desire for a disorderly unwind.
This email is not registered. Please subscribe to read article.
www.platinumworldportfolios.ie, is operated by Platinum World Portfolios PLC, a variable capital investment company incorporated under the laws of Ireland under Registered Number 546481 ("the Company", “we” or “us”).
By proceeding to access, view or download information from this website, you acknowledge that you have read, and agree to be bound by, the following terms and conditions. If you do not agree to these terms and conditions, you must not use this website.